Cleared Traditional

K962402 - AMO PRESTIGE DAY PACK (ALLERGAN

K962402 is the FDA 510(k) clearance for AMO PRESTIGE DAY PACK (ALLERGAN by Allergan, Inc.. It is a Class 2 Ophthalmic device (product code HQC) cleared through the Traditional 510(k) pathway after a 90-day FDA review.

K962402 · Allergan, Inc. · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1996
Decision
90d
Days
Class 2
Risk

K962402 is an FDA 510(k) clearance for the AMO PRESTIGE DAY PACK (ALLERGAN, INC.). Classified as Unit, Phacofragmentation (product code HQC), Class II - Special Controls.

Submitted by Allergan, Inc. (Irvine, US). The FDA issued a Cleared decision on September 19, 1996 after a review of 90 days - within the typical 510(k) review window.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4670 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Ophthalmic review framework, consistent with the majority of Class II 510(k) submissions.

View all Allergan, Inc. devices

Submission Details

510(k) Number K962402 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 21, 1996
Decision Date September 19, 1996
Days to Decision 90 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
20d faster than avg
Panel avg: 110d · This submission: 90d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code HQC Unit, Phacofragmentation
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4670
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HQC Unit, Phacofragmentation

All 98
Devices cleared under the same product code (HQC) and FDA review panel - the closest regulatory comparables to K962402.
AMO DIPLOMAX/OPSYS CONSOLE
K971186 · Allergan, Inc. · Jun 1997
HANDPIECE FOR NIDEK CV-12000 PHACO SYSTEM
K960287 · Nidek, Inc. · Nov 1996
STORZ D7120 PHACO HANDPIECE MAINTENANCE KIT & STORZ D7125 PHACO HANDPIECE NEEDLE WRENCH
K960024 · Storz Instrument Co. · Sep 1996
STORZ D7116 MICROVIT VITRECTOMY CUTTER EXTENSION
K960003 · Storz Instrument Co. · Aug 1996
STORZ D4600 AIR EXCHANGE LINE PACK
K962131 · Storz Instrument Co. · Aug 1996
STORZ DP5200 IRRIGATION ADDMINISTRATION SET PACK
K961831 · Storz Instrument Co. · Aug 1996